Therapeutic Asset Ratings
4,337 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bxcl501
Adjuvants
Cairo University
N/A
D
(30)
Bxcl501
Aminophylline
Tanta University
N/A
D
(30)
Bxcl501
Analgesic Non-narcotic
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
Analgesics
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
Analgesics Non-narcotic
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
Atrial Fibrillation
Beijing Anzhen Hospital
N/A
D
(30)
Bxcl501
Bariatric Surgery (Sleeve Gastrectomy )
IVO JURISIC
N/A
D
(30)
Bxcl501
Bariatric Surgical Pain
IVO JURISIC
N/A
D
(30)
Bxcl501
Metastatic Malignant Neoplasm
Samsung Medical Center
N/A
D
(30)
Bxcl501
Cancer Recurrence
University of Ioannina
N/A
D
(30)
Bxcl501
Carpal Tunnel Syndrome
Assiut University
N/A
D
(30)
Bxcl501
Central Nervous System Depressants
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
Cholecystectomy
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
Chronic Knee Pain
Tanta University
N/A
D
(30)
Bxcl501
Chronic Obstructive Pulmonary Disease
Tanta University
N/A
D
(30)
Bxcl501
Colorectal Neoplasm
Tam Anh Research Institute
N/A
D
(30)
Bxcl501
Critical Illness
First Affiliated Hospital of Wannan Medical College
N/A
D
(30)
Bxcl501
Deep Sedation
Beijing Anzhen Hospital
N/A
D
(30)
Bxcl501
Delirium
Benha University
N/A
D
(30)
Bxcl501
Fentanyl
Aretaieion University Hospital
N/A
D
(30)
Bxcl501
General Anesthesia
Cairo University
N/A
D
(30)
Bxcl501
Goiter
Udayana University
N/A
D
(30)
Bxcl501
Hyperthyroidism
Udayana University
N/A
D
(30)
Bxcl501
Inflammatory Disease
Samsung Medical Center
N/A
D
(30)
Bxcl501
Inflammatory Response
Udayana University
N/A
D
(30)
Showing 576 to 600 of 4,337 assets
Previous
Page 24 of 174
Next